Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool.

Christopher W J McChalicherMary-Jane LombardoSahil KhannaGregory J McKenzieElizabeth M HalvorsenSanabel AlmomaniBrian SchusterBrooke R HassonBarbara H McGovernDavid S EgeJohn G Auniņš

Published in: The Journal of infectious diseases (2023)

These experiments demonstrate substantial and rapid inactivation of representative organisms, supporting the potential benefit of VOS manufacturing processes to mitigate risk.

Keyphrases

gram negative
human health